Ethical aspects of pediatric palliative care

Journal of Palliative Care

Volumn 12, Issue 3, 1996, Pages 35-39

  Levetown, Marcia ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CASE REPORT; CHILD; COMPREHENSION; DEATH AND EUTHANASIA; DECISION MAKING; FEMALE; HUMAN; INFORMED CONSENT; INTERNATIONAL COOPERATION; LEGAL ASPECT; MALE; MEDICAL ETHICS; MENTAL STRESS; METHODOLOGY; NEWBORN; PALLIATIVE THERAPY; PATIENT PARTICIPATION; PROGNOSIS; REVIEW; TREATMENT WITHDRAWAL; UNCERTAINTY; UNITED STATES;

DEATH AND EUTHANASIA;

ADOLESCENT; CHILD; COMPREHENSION; DECISION MAKING; ETHICS, MEDICAL; FEMALE; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; INTERNATIONALITY; MALE; PALLIATIVE CARE; PATIENT PARTICIPATION; PROGNOSIS; STRESS, PSYCHOLOGICAL; UNCERTAINTY; UNITED STATES; WITHHOLDING TREATMENT;

EID: 0030236593     PISSN: 08258597     EISSN: None     Source Type: Journal    
DOI: 10.1177/082585979601200308     Document Type: Article

References (47)

1. Rosof BD. The Worst Loss: How Families Heal From the Death of a Child. New York Henry Holt and Co, 1994.
2. Mulhearn RK, Lauer ME, Hoffmann RG. Death of a child at home or in the hospital: subsequent psychological adjustment of the family. Pediatrics 1983; 71(5): 743-747.
3. Martinson IM, Armstrong GD, Geis DP, Anglim MA, Gronseth EC, MacInnis H, Kersey JH, Nesbit ME. Home care for children dying of cancer. Pediatrics 1978; 62(1): 106-113.
4. Levetown M. Barriers to Pediatric Palliative Care: Results of a National Survey, unpublished. Presented at the Academy of Hospice Physicians annual meeting, Vancouver, British Columbia, 1995.
5. Guidelines for the Determination of Terminal Illness in Non-Cancer Patients. Arlington, Virginia: National Hospice Organization, 1995.
6. Fischer AF, Stevenson DK. The consequences of uncertainty: an empirical approach to medical decision making in neonatal intensive care. JAMA 1987; 258(14): 1929-1931.
7. Logan RL, Scott PJ. Uncertainty in clinical practice: implications for quality and costs of health care. Lancet 1996; 347: 595-598.
8. Rizzo JA. Physician uncertainty and the art of persuasion. Soc Sci Med 1993; 37(12): 1451-1459.
9. Rhoden NK. Treating Baby Doe: the ethics of uncertainty. Hastings Center Report 1986; 16: 34-42.
10. Versluys C. To do or not to do: the ethics of neonatal care. In: Burgio GR, Lantos JD (eds). Primum Non Nocere Today, A Symposium on Pediatric Bioethics. New York Elsevier, 1994; 51-65.
11. Hastings Center Project on Imperiled Newborns. Anonymous. Section 2: The effect of new pediatric capabilities and the problem of uncertainty. Hastings Center Report 1987; 17(6): 10-13.
12. Stinson R, Stinson P. The Long Dying of Baby Andrew. Boston: Little, Brown & Co., 1992.
13. Lantos JD, Tyson JE, Allen A, Frader J, Hack M, Korones S, Merenstein, Paneth N, Poland RL, Saigal S, Stevenson D, Truog RD, Van Marter LJ. Withholding and withdrawing life-sustaining treatment in neonatal intensive care: issues for the 1990s. Arch Dis Child 1994; 71: F218-F223.
14. Doyal L, Wilsher D. Towards guidelines for withholding and withdrawal of life-prolonging treatment in neonatal medicine. Arch Dis Child 1994; 70: F66-F70.
15. Bioethics Committee, Canadian Paediatric Society. Can Med Assoc J 1986; 135: 447-448.
16. Kopelman LM, Irons TG, Kopelman AE. Neonatologists judge the "Baby Doe" regulations. N Engl J Med 1988; 318(11): 677-683.
17. Nelson LJ. Forgoing treatment of critically ill newborns and the legal legacy of Baby Doe. Clin Ethics Rep 1992; 6(2): 1-6.
18. Lantos J. Baby Doe five years later: Implications for child health. N Engl J Med 1987; 317(7): 444-147.
19. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the patient or the doctor? Brit J Cane 1988; 57(1): 109-112.
20. Cassell EJ. The nature of suffering and the goals of medicine. N Engl J Med 1982; 306(11): 639-645.
21. Leikin SL. Risks of research on children. J Peds 1982; 100: 166.
22. Roberts E. Refusal of treatment by 16 year old. Lancet 1992; 22, pt 2: 502-507.
23. Gamulka BD. Ethical uncertainly: an approach to decisions involving extracorporeal membrane oxygenation. Can Med Assoc J 1994; 150(4): 565-568.
24. Bluebond-Langner M. The Private Worlds of Dying Children. Princeton: Princeton University Press, 1978.
25. Susman EJ, Hersh SP, Nannis ED, et al. Conceptions of cancer; the perspectives of child and adolescent patients and their families. J Ped Psych 1982; 7(3): 253-261.
26. Leikin SL. The role of adolescents in decisions concerning their cancer therapy. Can Suppl 1993; 71(10): 3342-3346.
27. Bartholome WG. A new understanding of consent in pediatric practice: consent, parental permission and assent. Ped Annals 1989; 18(4): 262-265.
28. Freyer DR. Children with cancer: special considerations in the discontinuation of life-sustaining treatment. J Med Ped Oncol 1992; 20: 136-142.
29. King NMP, Cross AW. Children as decision-makers: guidelines for pediatricians. J Peds 1989; 115(1): 10-16.
30. Doyal L, Henning P. Stopping treatment for end-stage renal failure: the rights of children and adolescents. J Ped Neph 1994; 8: 768-791.
31. Committee on Bioethics, American Academy of Pediatrics. Informed consent, parental permission and assent in pediatric practice. Pediatrics 1995; 95(2): 314-317.
32. Leikin S. A proposal concerning decisions to forgo life-sustaining treatment for young people. J Peds 1989; 115(1): 17-22.
33. Feeg VD. Ethics lessons in a teenager's story. Ped Nurs 1994; 20(5): 436.
34. Grisso T, Vierling L. Minors' consent to treatment: a developmental perspective. Prof Psychol 1978; 9(3): 412-427.
35. Rushton CH. Commentary: guidelines on forgoing life-sustaining medical treatment. Ped Nurs 1994; 20(5): 522.
36. Drane JF. Competency to give an informed consent: a model for making clinical assessments. JAMA 1984; 252(7): 925-927.
37. Committee on Bioethics, American Academy of Pediatrics. Guidelines on forgoing life-sustaining medical treatment. Pediatrics 1994; 93(3): 532-536.
38. Jonsen AR. Research involving children: recommendations of the national commission for the protection of human subjects of biomedical and behavioral research. Pediatrics 1978; 62(2): 131-136.
39. Tyson J. Evidence-based ethics and the care of premature infants. The Future of Children 1995; 5(1): 197-221.
40. Tyson J. The boundary between therapeutic and non-therapeutic research. In: Goldworth A, Silverman W, Stevenson DK, Young EWD, Rivers R. Ethics and Perinatology. New York: Oxford University Press, 1995; 214-230.
41. American Academy of Pediatrics, Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics 1977; 60(1): 91-101.
42. Janofsky J, Starfield B. Assessment of risk in research on children. J Peds 1981; 98(5): 842-846.
43. King NMP. Experimental treatment: oxymoron or aspiration? Hastings Center Report 1995; 25(4): 6-15.
44. O'Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehi CW, Parad RB, Epstein MF. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989; 84: 957-963.
45. Knox RA. A Harvard study on newborns draws fire. Doctors faulted for limiting life-saving treament. Boston Globe, Monday, August 7, 1989, Third Section: Science and Technology, p. 25.
46. Nitschke R, Humphrey GB, Sexauer CL, Catron B, Wunder S, Jay S. Therapeutic choices made by patients with end-stage cancer. J Peds 1982; 101(3): 471-476.
47. Applebaum PS, Roth LH, Lidz CW, Benson P, Winslade W. False hopes and best data: consent to research and the therapeutic misconception. Hastings Center Report 1987; 17(2): 20-24.